Valneva SE
NASDAQ:VALN
Valneva SE
NASDAQ:VALN
Price:
10.31
USD
-5.59%
Market Closed
Market Cap:
$717.3m
Relative Value
The Relative Value of one
VALN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 10.31 USD,
Valneva SE
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VALN Relative Value
HIDDEN
Multiples Across Competitors
VALN Competitors Multiples
Valneva SE Competitors
Valneva SE Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Valneva SE
NASDAQ:VALN
|
743.6m USD | 2.7 | -6.2 | -7.9 | -7.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
415.6B USD | 6.8 | 98.9 | 16.2 | 22.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.5B USD | 5.5 | 26.4 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.3B USD | 6.2 | 21.6 | 13.4 | 16.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.7B USD | 10 | 30.5 | 23 | 24 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.6B USD | 5.7 | 18.1 | 13.5 | 15.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70B AUD | 3.2 | 35.6 | 11.7 | 14.7 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.4B EUR | 11.2 | 36.1 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
